CerviPrep

gemcitabine (topical formulation)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CerviPrep, covering 2010-06-17 to 2010-06-17. Get the full timeline:

Most recent: Clinical Trial Update: CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer [Phase 2]

See pricing